T. Rowe Price Associates
IVVD icon

T. Rowe Price Associates’s Invivyd IVVD Stock Holding History

T. Rowe Price Associates’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,716
Closed -$22K – 3101
2025
Q1 		$22K Buy
35,716
+9,956
+39% +$8.93K ﹤0.01% 3000
2024
Q4 		$12K Hold
25,760
– – ﹤0.01% 3004
2024
Q3 		$27K Hold
25,760
– – ﹤0.01% 2975
2024
Q2 		$0 Buy
+25,760
New +$56.9K ﹤0.01% 2976
2023
Q2 		– Sell
-46,639
Closed -$56K – 2914
2023
Q1 		$56K Sell
46,639
-466,564
-91% -$852K ﹤0.01% 2776
2022
Q4 		$769K Sell
513,203
-59,251
-10% -$165K ﹤0.01% 1915
2022
Q3 		$1.79M Buy
572,454
+51,505
+10% +$206K ﹤0.01% 1502
2022
Q2 		$1.71M Buy
520,949
+19,884
+4% +$62.3K ﹤0.01% 1673
2022
Q1 		$2.29M Buy
501,065
+36,144
+8% +$221K ﹤0.01% 1643
2021
Q4 		$3.38M Buy
+464,921
New +$12.1M ﹤0.01% 1559

Other funds holding IVVD

MIG
Mithril II GP Austin, Texas $64.5M AUM 360.75% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates's IVVD Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Invivyd (IVVD) in Q2 2025, closing a stake of 35,716 shares — an estimated $22K sold.

T. Rowe Price Associates first reported a position in IVVD in Q4 2021 and held it in 10 quarters. The position peaked at $3.38M in Q4 2021. 68 funds tracked by Wall St. Rank hold IVVD as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Invivyd position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 35,716 Invivyd shares in Q2 2025, an estimated $22K.
  • T. Rowe Price Associates first reported a position in Invivyd in Q4 2021 and held it in 10 quarters.
  • T. Rowe Price Associates's Invivyd position peaked at $3.38M in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Invivyd as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.